摘要
钚在体内长期滞留是一个强的致癌物质.本文综述了几种不同类型螫合剂的结构特点以及对钚的促排情况,介绍仿生化学设计合成钚促排药物的基本原理,分析了今后钚促排药物研究的动向.
出处
《国外医学（放射医学核医学分册）》
北大核心
1990年第5期197-200,共4页
Foreign Medical Sciences(Section of Radiation Medicine and Nuclear Medicine)
参考文献1
-
1Zbigniew Szot,Ma?gorzata Rochalska,Maria Wojewódzka,Andrzej Chimiak,Witold Przychodzen. Removal of239Pu from mice with 3,4,3 LICAM(C) or N, N′, N″, N?-tetra-(2,3-dihydroxybenzoyl)-spermine[J] 1986,Radiation and Environmental Biophysics(1):31～35
同被引文献13
-
1Anne E, Gorden J X, Kenneth N R. Rational Design of Sequestering Agents for Plutonium and other Actinides. Chemical Reviews, 2003,103( 11 ) :4207.
-
2Oghiso Y, Yamada Y. Comparisons of Pulmonary Carcinogenesis in Rats Following Inhalation Exposure to Plutonium Dioxide or X-ray Irradiation. J. Radiat. Res., 2003,44 (3):261.
-
3Iannoshenko I V, Kirdin I A, ZhukovskilM V. The Relative Biological Effectiveness of Alpha-radiation During Human Lung Exposure to Irradiation. Radiat. Biol. Radioecol., 2005,45(4) :422.
-
4Grogan H A, Sinclair W K, Voillegue P G. Risk of Fatal Cancer from Inhalation of 239, 240 plutonium by humans: a Combined Fourmethod Approach with Uncertainty Evaluation. Health Phys., 2001,80(5):447.
-
5Durbin P W, Kullgren B, Xu J, et al. Muhidentate Hydroxypyridinonate Ligands for Pu(Ⅳ) Chelation in Vivo: Comparative eY Cacy and Toxicity in Mouse of Ligands Containing 1,2-HOPO or Me-3,2-HOPO. Int. J. Radiat. Biol., 2000,76(2) : 199.
-
6Glenn N T, Charles W M. Fetal Injury Induced by Ca-DTPA in Dogs. Health Physics. 1978,35 : 860.
-
7Lloyd R D, Bruenger F W, Mays C W, et al. Removal of Pu and Am from Beagles and Mice by 3,4,3-LICAM(C) or 3,4,3-LICAM(S). Radiat. Res., 1984,99(1):106.
-
8Mays C W, Lloyd R D, Jones C W, et al. Decorporation of Pu and Am from Beagles with Delayed Daily Injections of 3, 4,3-LICAM(C) or Zn-DTPA. Health Phys., 1986, 50 (4) :530.
-
9Durbin P W, Kullgren B, Jeung N, et al. Octadentate Catecholamide Ligands for Pu(Ⅳ) Based on Linear or Preorganized Molecular Backbones. Hum. Exp. Toxicol., 1996, 15(4) :352.
-
10Volf V, Burgada R, Raymond K N, et al. Early Chelation Therapy for Injected Pu-238 and Am-241 in the Rat: Comparisionof 3,4,3-LIHOPO, DFO-HOPO, DTPA-DX, DTPA and DFOA. Int. J. Radiat. Biol., 1993, 63(6):785.
-
1陈文致,谢毓元.铀促排药物研究:Ⅳ,N,N′-双-[N-羧甲基-(2,3-二羟基-5-甲氧羰基苄胺乙酰基]-α,ω-二胺的合成[J].药学学报,1990,25(10):790-794. 被引量：1
-
2王慧才,纪立顺.锕系元素的螯合药物——Ⅸ.1-羟基-2(1H)-吡啶酮类衍生物的合成[J].山东医科大学学报,1990,28(4):68-71.
-
3杜娟,孙梅贞,薛芬.锕系核素促排药物——多元酚氨羧酸衍生物的合成[J].药学学报,1989,24(9):711-714.
-
4覃兆海,谢毓元.铀促排药物研究Ⅵ:2,3-二羟基-4-甲氧羰基苄基胺羧酰胺螯合剂的合成[J].药学学报,1993,28(8):619-622. 被引量：4
-
5廖琪丽,胡文祥,周志明,王建营,程天民.羟基吡啶酮促排铀和钚的研究进展[J].中国药物化学杂志,2005,15(1):60-64. 被引量：3
-
6罗梅初,陈红红.放射性核素内污染促排药物研究[J].中华放射医学与防护杂志,2000,20(1):11-14. 被引量：11
-
7赵书彦,张淑贤,封觉,张康蓉,孟宪钰,庄小玲,陈如松.新螯合剂FZ-82-4的毒性实验研究[J].中华放射医学与防护杂志,2001,21(1):34-35. 被引量：1
-
8陈文致,谢毓元.铀促排药物研究Ⅴ.一种带有膦酸及羧酸基团的酚型螯合剂的合成[J].中国药物化学杂志,1992,2(1):36-39. 被引量：4
-
9任红玉,王慧才.锕系元素的螯合药物——Ⅹ.新型镅促排药物的研究[J].山东医科大学学报,1991,29(1):81-84.
-
10张少芳,张翠欣.桉柠蒎软胶囊的质量控制和临床应用研究进展[J].临床合理用药杂志,2014,7(5):173-174. 被引量：11
